Luminex Acquires GenturaDX, Inc.; Wins M&A Deal of the Year

Client Type: Public Company

The firm assisted Luminex Corporation in its acquisition of Gentura DX, Inc., a BVI Corporation. The acquisition was valued at $50 million. The firm received an “M&A Deal of the Year” award as part of the 11th Annual M&A Advisor Awards for our work on behalf of Luminex Corporation in connection with this transaction. The Luminex transaction also was named a finalist for “Sector Deal of the Year” in the “Healthcare / Life Sciences (between $10 million and $100 million)” category.

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

The firm assisted Luminex Corporation in its acquisition of Gentura DX, Inc., a BVI Corporation. The acquisition was valued at $50 million. The firm received an “M&A Deal of the Year” award as part of the 11th Annual M&A Advisor Awards for our work on behalf of Luminex Corporation in connection with this transaction. The Luminex transaction also was named a finalist for “Sector Deal of the Year” in the “Healthcare / Life Sciences (between $10 million and $100 million)” category.

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.